MD+DI Senior Editor Amanda Pedersen highlights FDA's use of a chief medical officer's name in a recent warning letter to ExThera for unapproved claims.

MD+DI is hosting an exclusive webinar in collaboration with L.E.K. Consulting and sponsored by Epicor to uncover how outsourced contract manufacturing organizations (CMOs) are evolving into critical ...

Retractable Technologies reported that it was reducing its workforce by about 16%. The move comes as the Little Elm, TX-based company reported it was strengthening its domestic production capabilities ...

Michael McGee, CEO of Freudenberg Medical, shares how AI reduces development iterations, robotics upskill workers, and ...

Medical Device OEMs are looking to simplify relationships with suppliers by contracting with fewer vendors who can handle ...

Pulse Biosciences is keeping the noise level up by announcing the enrollment of the first patients in the NANOPULSE-AF study, a prospective, multicenter, IDE pivotal clinical investigation currently ...

CDMO platforms are driving Medtech M&A in 2026 as buyers seek specialized capabilities like precision diagnostics and ...

StairMed raises $73M from Alibaba and Tencent for brain-computer interface development and plans 40 patient implants by 2026 ...

Rhythm Technologies CFO Daniel Wilson joins us on this episode of Let's Talk Medtech to discuss the company's expansion into ...

How can you ensure that you’ve selected the right contract design and manufacturing organization? We’re going to tell you how ...